Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 4;15(8):13482-93.
doi: 10.3390/ijms150813482.

Melatonin and atopy: role in atopic dermatitis and asthma

Lucia Marseglia  1 , Gabriella D'Angelo  2 , Sara Manti  3 , Carmelo Salpietro  4 , Teresa Arrigo  5 , Ignazio Barberi  6 , Russel J Reiter  7 , Eloisa Gitto  8
Affiliations
Review

Melatonin and atopy: role in atopic dermatitis and asthma

Lucia Marseglia et al. Int J Mol Sci. .

Abstract

Melatonin may have important immunostimulatory actions in allergic diseases, in addition to its well-known antioxidant and cytoprotective effects in several inflammatory conditions. The activation of the immune system leads to free radical production associated with decreased melatonin levels and depressed antioxidant enzyme activities in several inflammatory diseases. Many skin disorders, including atopic dermatitis, are accompanied by infiltration and activation of mast cells, which release vasoactive and proinflammatory mediators. Experimental data suggest that melatonin inhibits development of atopic eczema and reduces serum total IgE and IL-4. Allergic asthma is a condition characterized by bronchial hyperresponsiveness and the presence of IgE antibodies in response to inhaled allergens; often there is also enhanced total serum IgE levels. Melatonin regulates smooth muscle tone and influences the immune response. Melatonin may, however, act as a pro-inflammatory agent in asthma leading to bronchial constriction. The safety of melatonin as a sleep-inducing agent has been confirmed in asthmatic subjects, but its routine use is not recommended in bronchial asthma. This review summarizes what is known about the role of melatonin as an immunomodulatory agent in asthma and atopic eczema.

PubMed Disclaimer

References

    1. Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., Kowalski M.L., Mygind N., Ring J., van Cauwenberge P., et al. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–824. doi: 10.1034/j.1398-9995.2001.t01-1-00001.x. - DOI - PubMed
    1. Romagnani S. Induction of TH1 and TH2 responses: A key role for the natural immune response? Immunol. Today. 1992;13:379–381. doi: 10.1016/0167-5699(92)90083-J. - DOI - PubMed
    1. Brown V.G., Ennis M. T cell cytokine production in childhood asthma. Curr. Respir. Med. Rev. 2005;1:1–6. doi: 10.2174/1573398052953677. - DOI
    1. Cohn L., Elias J.A., Chupp G.L. Asthma: Mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004;22:789–815. doi: 10.1146/annurev.immunol.22.012703.104716. - DOI - PubMed
    1. Schmidt-Weber C.B., Akdis M., Akdis C.A. TH17 cells in the big picture of immunology. J. Allergy Clin. Immunol. 2007;120:247–254. doi: 10.1016/j.jaci.2007.06.039. - DOI - PubMed